Aytu BioPharma Inc

AYTU

Company Profile

  • Business description

    Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

  • Contact

    7900 East Union Avenue
    Suite 920
    DenverCO80237
    USA

    T: +1 720 437-6580

    E: [email protected]

    https://www.aytubio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    30 June 2026

    Employees

    83

Stocks News & Analysis

stocks

Earnings up but shares overvalued for ASX gold miner

Higher gold prices are making a difference to the bottom line but investors overly optimistic.
stocks

Alphabet: Anthropic deal and Gemini momentum stand to deliver; Fair Value up 27%

We see faster cloud growth and improved longer-term profitability for Alphabet.
stocks

Overvalued ASX mining giant

Solid start to 2026 but shares overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,351.904.90-0.05%
CAC 408,215.5910.04-0.12%
DAX 4024,228.1411.75-0.05%
Dow JONES (US)47,207.12472.511.01%
FTSE 1009,656.5510.930.11%
HKSE26,433.70273.551.05%
NASDAQ23,204.87263.071.15%
Nikkei 22550,512.321,212.672.46%
NZX 50 Index13,391.5914.490.11%
S&P 5006,791.690.000.00%
S&P/ASX 2009,055.602.20-0.02%
SSE Composite Index3,996.9446.631.18%

Market Movers